Results 41 to 50 of about 5,687 (109)

Effective sequential therapy of linezolid and contezolid against HA-MRSA-induced necrotizing pneumonia in a 95-year-old patient with multimorbidity. [PDF]

BMC Infect Dis
Wang R, Shen S, Zheng T, Zhang Y, Xu W, Wu J.   +5 more
europepmc   +1 more source

Concentration of contezolid in cerebrospinal fluid and serum in a patient with renal allograft tuberculosis and tuberculous meningoencephalitis. [PDF]

BMC Infect Dis
Liu W, He T, Qin H, Zhang P.
europepmc   +1 more source

Warfarin-Linezolid Interaction: A Case of Severe Coagulopathy. [PDF]

Case Rep Infect Dis
Batool A, Khan W, Mohsin M.
europepmc   +1 more source

Risk of Treatment Failure in Outpatient Parenteral Antimicrobial Therapy From an Academic Medical Center in Kentucky. [PDF]

Open Forum Infect Dis
Worsham Behal K, Stoner BJ, Schadler A, Burgess D, Burgess DS, Mynatt RP.   +5 more
europepmc   +1 more source

Treatment of Tuberculous Meningitis With Contezolid in a Patient With Complex Comorbidities: A Case Report and Literature Review. [PDF]

Case Rep Infect Dis
Fan Q, Sun H, Liu S.
europepmc   +1 more source

Regio-reversed alkenyl-arylation of ynamides <i>via</i> 1,3-olefin shift. [PDF]

Chem Sci
Verma S, Sethi M, Sahoo AK.
europepmc   +1 more source

Pathway to P(V)-Stereogenic Phosphoramidates by Enantioselective Yttrium Catalysis. [PDF]

J Am Chem Soc
Daniels BS, Blackburn BG, Scribner SJ, Dong VM.   +3 more
europepmc   +1 more source

Multi-replicon Architecture Drives the Global Accumulation of Resistance to Antimicrobials, Biocides, and Metals in IncF and IncH Plasmids. [PDF]

Curr Microbiol
de Souza HCA, de Oliveira Almeida AC, ConteJunior CA, Panzenhagen P.   +3 more
europepmc   +1 more source

Improved Radiosynthesis of [¹⁸F]-Labeled Oxazolidinone Antibiotics for Future Clinical Translation. [PDF]

ACS Infect Dis
Sarhan M, Shelke AM, Mane K, Jadhav R, Jeon B, Nino-Meza O, Chen X, Freundlich JS, Jain SK, Carroll L.   +9 more
europepmc   +1 more source

Discovery and development of a new oxazolidinone with reduced toxicity for the treatment of tuberculosis. [PDF]

Nat Med
Crowley BM, Boshoff HI, Boving A, Tan VY, Zhu J, Hoyt F, Miller RR, Ehrhart J, Boyce CW, Young K, Nantermet PG, Su J, Yang L, Painter RE, Corcoran EB, Hoar JL, Oh S, Holtzman DL, Levi M, Anderson A, Otieno MA, Zimmerman M, Kaya F, Massoudi LM, Ramey ME, Bauman AA, Lenaerts AJ, Roberston GT, Dartois V, Wells CD, Barry CE, Olsen DB.   +31 more
europepmc   +1 more source